Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
- PMID: 28403580
- PMCID: PMC5362548
- DOI: 10.18632/oncotarget.15755
Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
Erratum for
-
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.Oncotarget. 2015 Oct 6;6(30):30194-211. doi: 10.18632/oncotarget.4734. Oncotarget. 2015. PMID: 26327203 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources